159 related articles for article (PubMed ID: 20089134)
1. Parkin regulates metal transport via proteasomal degradation of the 1B isoforms of divalent metal transporter 1.
Roth JA; Singleton S; Feng J; Garrick M; Paradkar PN
J Neurochem; 2010 Apr; 113(2):454-64. PubMed ID: 20089134
[TBL] [Abstract][Full Text] [Related]
2. Isoform specific regulation of divalent metal (ion) transporter (DMT1) by proteasomal degradation.
Garrick MD; Zhao L; Roth JA; Jiang H; Feng J; Foot NJ; Dalton H; Kumar S; Garrick LM
Biometals; 2012 Aug; 25(4):787-93. PubMed ID: 22310887
[TBL] [Abstract][Full Text] [Related]
3. Divalent metal transporter 1 (DMT1) regulation by Ndfip1 prevents metal toxicity in human neurons.
Howitt J; Putz U; Lackovic J; Doan A; Dorstyn L; Cheng H; Yang B; Chan-Ling T; Silke J; Kumar S; Tan SS
Proc Natl Acad Sci U S A; 2009 Sep; 106(36):15489-94. PubMed ID: 19706893
[TBL] [Abstract][Full Text] [Related]
4. The S-nitrosylation of parkin attenuated the ubiquitination of divalent metal transporter 1 in MPP
Zhong Y; Li X; Du X; Bi M; Ma F; Xie J; Jiang H
Sci Rep; 2020 Sep; 10(1):15542. PubMed ID: 32968192
[TBL] [Abstract][Full Text] [Related]
5. 1B/(-)IRE DMT1 expression during brain ischemia contributes to cell death mediated by NF-κB/RelA acetylation at Lys310.
Ingrassia R; Lanzillotta A; Sarnico I; Benarese M; Blasi F; Borgese L; Bilo F; Depero L; Chiarugi A; Spano PF; Pizzi M
PLoS One; 2012; 7(5):e38019. PubMed ID: 22666436
[TBL] [Abstract][Full Text] [Related]
6. Proteasomal inhibition reduces parkin mRNA in PC12 and SH-SY5Y cells.
Koch A; Lehmann-Horn K; Dächsel JC; Gasser T; Kahle PJ; Lücking CB
Parkinsonism Relat Disord; 2009 Mar; 15(3):220-5. PubMed ID: 18586549
[TBL] [Abstract][Full Text] [Related]
7. NAC1, A POZ/BTB protein interacts with Parkin and may contribute to Parkinson's disease.
Korutla L; Furlong HA; Mackler SA
Neuroscience; 2014 Jan; 257():86-95. PubMed ID: 24231739
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide transcriptionally down-regulates specific isoforms of divalent metal transporter (DMT1) via NF-kappaB.
Paradkar PN; Roth JA
J Neurochem; 2006 Mar; 96(6):1768-77. PubMed ID: 16539692
[TBL] [Abstract][Full Text] [Related]
9. Transgenic Mice Overexpressing the Divalent Metal Transporter 1 Exhibit Iron Accumulation and Enhanced Parkin Expression in the Brain.
Zhang CW; Tai YK; Chai BH; Chew KCM; Ang ET; Tsang F; Tan BWQ; Hong ETE; Asad ABA; Chuang KH; Lim KL; Soong TW
Neuromolecular Med; 2017 Sep; 19(2-3):375-386. PubMed ID: 28695462
[TBL] [Abstract][Full Text] [Related]
10. Parkin loss of function contributes to RTP801 elevation and neurodegeneration in Parkinson's disease.
Romaní-Aumedes J; Canal M; Martín-Flores N; Sun X; Pérez-Fernández V; Wewering S; Fernández-Santiago R; Ezquerra M; Pont-Sunyer C; Lafuente A; Alberch J; Luebbert H; Tolosa E; Levy OA; Greene LA; Malagelada C
Cell Death Dis; 2014 Aug; 5(8):e1364. PubMed ID: 25101677
[TBL] [Abstract][Full Text] [Related]
11. Increased hippocampal expression of the divalent metal transporter 1 (DMT1) mRNA variants 1B and +IRE and DMT1 protein after NMDA-receptor stimulation or spatial memory training.
Haeger P; Alvarez A; Leal N; Adasme T; Núñez MT; Hidalgo C
Neurotox Res; 2010 Apr; 17(3):238-47. PubMed ID: 19655216
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of Parkin and its mutants on protein aggregation, the ubiquitin-proteasome system, and neuronal cell death in human neuroblastoma cells.
Kyratzi E; Pavlaki M; Kontostavlaki D; Rideout HJ; Stefanis L
J Neurochem; 2007 Aug; 102(4):1292-303. PubMed ID: 17472700
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells overexpressing Parkin.
Ardley HC; Scott GB; Rose SA; Tan NG; Markham AF; Robinson PA
Mol Biol Cell; 2003 Nov; 14(11):4541-56. PubMed ID: 12937272
[TBL] [Abstract][Full Text] [Related]
14. Parkin reverses intracellular beta-amyloid accumulation and its negative effects on proteasome function.
Rosen KM; Moussa CE; Lee HK; Kumar P; Kitada T; Qin G; Fu Q; Querfurth HW
J Neurosci Res; 2010 Jan; 88(1):167-78. PubMed ID: 19610108
[TBL] [Abstract][Full Text] [Related]
15. Intestinal DMT1 cotransporter is down-regulated by hepcidin via proteasome internalization and degradation.
Brasse-Lagnel C; Karim Z; Letteron P; Bekri S; Bado A; Beaumont C
Gastroenterology; 2011 Apr; 140(4):1261-1271.e1. PubMed ID: 21199652
[TBL] [Abstract][Full Text] [Related]
16. Neddylation positively regulates the ubiquitin E3 ligase activity of parkin.
Um JW; Han KA; Im E; Oh Y; Lee K; Chung KC
J Neurosci Res; 2012 May; 90(5):1030-42. PubMed ID: 22271254
[TBL] [Abstract][Full Text] [Related]
17. Functional properties of multiple isoforms of human divalent metal-ion transporter 1 (DMT1).
Mackenzie B; Takanaga H; Hubert N; Rolfs A; Hediger MA
Biochem J; 2007 Apr; 403(1):59-69. PubMed ID: 17109629
[TBL] [Abstract][Full Text] [Related]
18. Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: implications for regulation and cellular function.
Hubert N; Hentze MW
Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12345-50. PubMed ID: 12209011
[TBL] [Abstract][Full Text] [Related]
19. α-Synuclein Regulates Iron Homeostasis via Preventing Parkin-Mediated DMT1 Ubiquitylation in Parkinson's Disease Models.
Bi M; Du X; Jiao Q; Liu Z; Jiang H
ACS Chem Neurosci; 2020 Jun; 11(11):1682-1691. PubMed ID: 32379419
[TBL] [Abstract][Full Text] [Related]
20. The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration.
Corti O; Hampe C; Koutnikova H; Darios F; Jacquier S; Prigent A; Robinson JC; Pradier L; Ruberg M; Mirande M; Hirsch E; Rooney T; Fournier A; Brice A
Hum Mol Genet; 2003 Jun; 12(12):1427-37. PubMed ID: 12783850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
